|Articles|June 1, 2003

Doxorubicin, Interleukin-12 Join Against KS

Boston - Combined cytotoxic and antiangiogenic therapies may have synergistic effects in treating advanced Kaposi's sarcoma in patients with AIDS, according to Richard F. Little, M.P.H., M.D., senior clinical investigator, HIV and AIDS malignancy branch, Center for Cancer Research, National Cancer Institute.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME